Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
about
Fusarium infections in immunocompromised patientsComparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.Adjunctive immune therapy for fungal infections.Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus.The immune response to fungal infections.Cytokines and fungal infections.Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.Neutrophil in viral infections, friend or foe?Immunomodulatory therapy in yeast infections.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptorsAspergillus-associated airway disease, inflammation, and the innate immune responseCombination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.Immunotherapy against invasive mold infections.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Promising immunotherapy against fungal diseases.Micafungin enhances neutrophil fungicidal functions against Candida pseudohyphae.Cytokine profile of a self-healing Fonsecaea pedrosoi infection in murine model.Aspergillosis in solid organ transplantation.Human invasive mycoses: immunogenetics on the rise.Characterization and functional analysis of granulocyte concentrates collected from donors after repeated G-CSF stimulation.Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice.Subcutaneous hyalohyphomycosis caused by Fusarium in a kidney transplant recipient.Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
P2860
Q24685627-78325F6E-EC27-4948-AA00-9CDFAF65D6DDQ34008664-890800F5-FE2F-446D-ACEA-3543F9E84B54Q34183719-FDE5EE2E-1C4C-4106-812C-0439650B2493Q34350401-D7B644B1-2737-48AA-AA7E-5D10753F8398Q36138054-23B090D0-0688-4A85-B0B6-866DEFC1830AQ36139489-914D0F52-75A5-4EC4-BABA-EFC8278AC2CFQ36139494-3DF87482-4A84-4367-99D5-DDC7450077ADQ36389463-E4D071B5-7384-448F-B68F-0B097919FF9DQ36569374-8E3586BD-89DB-4A3F-8C6A-0FB09B11A6C2Q36723814-9F646501-53FA-4735-AEA5-ED838FB6D983Q36862446-0E5726FF-B9DE-4E96-BBC1-A3486AB09C5DQ36870941-7AB34004-9D9C-4211-AD96-F89CC24B7BA4Q37077782-F38289E1-C032-41D0-8196-9F0E78C3015AQ37078394-98136AF3-97B2-49E5-8CBC-BE5F5A32DB05Q37965757-C3C2B5B5-9DAA-471C-A8CA-A1D73324D77FQ38067451-B4A83DB8-40DD-49EF-8D4C-083543BF31FFQ38692399-BA2D9B7E-33DB-4A00-80F1-86E0FDDC6E5EQ40968286-93FD45AF-C19E-4348-9B67-DB4AE538837BQ42271654-88772FF4-CDD6-45A9-8002-5A828CE241A0Q42272291-67565A63-B9D2-4C9B-B61A-F02C92F82AFEQ42418094-06D25295-8B92-4D13-AA05-604826BCD9DFQ42522894-FA2BD966-628D-480F-B500-DBA0E3219EDAQ43777175-9396F217-7691-4E54-AC47-875187301881Q44430720-6BEE3359-3D60-4FD3-98D4-FF64FD899997Q46863064-74C80276-C0AF-43D2-B575-C6D70C7516CB
P2860
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@ast
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@en
type
label
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@ast
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@en
prefLabel
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@ast
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@en
P2093
P356
P1476
Comparison of interferon-gamma ...... pportunistic fungal pathogens.
@en
P2093
P304
P356
10.1086/314679
P407
P577
1999-04-01T00:00:00Z